Long-term follow-up cohort of hepatitis B in China: current status and perspectives
Hepatitis B virus (HBV) infection is a global public health issue, especially in the Asian-Pacific region. At present, entecavir, tenofovir, and pegylated interferon are the first-line antiviral drugs recommended by related guidelines for the prevention and treatment of hepatitis B; however, differe...
Main Authors: | HU Xiaoyun, SUN Jian |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2017-08-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8371 |
Similar Items
-
The Outcome of Status Epilepticus and Long-Term Follow-Up
by: László Horváth, et al.
Published: (2019-04-01) -
Treatment of Chronic Hepatitis B with Interferon: Long Term Follow-Up
by: Jean-Pierre Villeneuve, et al.
Published: (1996-01-01) -
Long‐term follow‐up in patients with Brugada Syndrome in South China
by: Donghua Zhao, et al.
Published: (2021-05-01) -
Long-Term Follow-Up of a Portuguese Single-Centre Cohort of Persons with Haemophilia and Hepatitis C Virus Infection
by: Tiago Pereira Guedes, et al.
Published: (2020-09-01) -
COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort
by: Myriam Calle Rubio, et al.
Published: (2021-02-01)